Want to see JP:7600 full AI Analyst Report?
7600 Stock Chart & Stats
¥487.00
-¥2.00(-0.33%)
At close: 4:00 PM EST
¥487.00
-¥2.00(-0.33%)
Day’s Range― - ―
52-Week Range¥445.00 - ¥1,005.00
Previous CloseN/A
Volume41.50K
Average Volume (3M)353.09K
Market Cap
¥16.78B
Enterprise Value¥27.28K
Total Cash (Recent Filing)¥2.56B
Total Debt (Recent Filing)¥6.63B
Price to Earnings (P/E)―
Beta0.87
Next Earnings
Nov 04, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield2.67%
Share Statistics
EPS (TTM)-8.37
Shares Outstanding26,475,880
10 Day Avg. Volume517,320
30 Day Avg. Volume353,093
Financial Highlights & Ratios
PEG Ratio-0.34
Price to Book (P/B)0.56
Price to Sales (P/S)0.59
P/FCF Ratio-8.06
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)2.3
Revenue Forecast (FY)¥25.30B
Bulls Say, Bears Say
Bulls Say
Balance Sheet ResilienceThe large equity base and moderate leverage provide a meaningful financial cushion as the company manages weaker operating conditions. Although debt has increased, the current capital structure still offers flexibility to support operations and absorb near-term earnings volatility.
Return To ProfitabilityReturning to positive earnings after the prior-year loss indicates that the business retains a functioning earnings base despite its current slowdown. If operating conditions stabilize, this profitability provides a foundation for recovery and reduces the risk associated with persistent losses.
Healthy Gross MarginA still-healthy gross margin suggests the company continues to retain some economic value in its medical-device distribution activities. This underlying gross-profit base could help management rebuild operating leverage if revenue stabilizes and cost pressures moderate over the coming quarters.
Bears Say
Revenue And Margin DeteriorationThe combination of shrinking revenue and sharply lower operating and net margins signals weakened demand or operating leverage, reducing the earnings produced by each sales yen. Persistently thin margins would leave little buffer against further disruption and make recovery more dependent on renewed growth.
Weak Cash GenerationDeeply negative free cash flow and sharply lower operating cash flow indicate that reported profitability is not currently translating into internally generated funds. This can increase funding needs, limit capital-allocation flexibility, and make sustained investment harder unless cash conversion improves.
Low Returns And Rising LeverageAlthough leverage remains moderate, its rise alongside very low return on equity points to less efficient use of the capital base. If earnings remain weak, additional debt could add financial obligations without producing attractive returns, constraining flexibility and slowing value creation.
Japan Medical Dynamic Marketing, Inc. News
7600 FAQ
What was Japan Medical Dynamic Marketing, Inc.’s price range in the past 12 months?
Japan Medical Dynamic Marketing, Inc. lowest stock price was ¥445.00 and its highest was ¥1005.00 in the past 12 months.
What is Japan Medical Dynamic Marketing, Inc.’s market cap?
Japan Medical Dynamic Marketing, Inc.’s market cap is ¥16.78B.
When is Japan Medical Dynamic Marketing, Inc.’s upcoming earnings report date?
Japan Medical Dynamic Marketing, Inc.’s upcoming earnings report date is Nov 04, 2026 which is in 52 days.
How were Japan Medical Dynamic Marketing, Inc.’s earnings last quarter?
Japan Medical Dynamic Marketing, Inc. released its earnings results on Jul 30, 2026. The company reported -¥15.85 earnings per share for the quarter.
Is Japan Medical Dynamic Marketing, Inc. overvalued?
According to Wall Street analysts Japan Medical Dynamic Marketing, Inc.’s price is currently Overvalued.
Does Japan Medical Dynamic Marketing, Inc. pay dividends?
Japan Medical Dynamic Marketing, Inc. pays a Annually dividend of ¥17 which represents an annual dividend yield of 2.67%. See more information on Japan Medical Dynamic Marketing, Inc. dividends here
What is Japan Medical Dynamic Marketing, Inc.’s EPS estimate?
Japan Medical Dynamic Marketing, Inc.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Japan Medical Dynamic Marketing, Inc. have?
Japan Medical Dynamic Marketing, Inc. has 26,475,880 shares outstanding.
What happened to Japan Medical Dynamic Marketing, Inc.’s price movement after its last earnings report?
Japan Medical Dynamic Marketing, Inc. reported an EPS of -¥15.85 in its last earnings report. Following the earnings report the stock price went down -3.444%.
Which hedge fund is a major shareholder of Japan Medical Dynamic Marketing, Inc.?
Currently, no hedge funds are holding shares in JP:7600
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Japan Medical Dynamic Marketing, Inc.
Japan Medical Dynamic Marketing, Inc. (JMDM) engages in the development, production, importation, and distribution of medical instruments throughout Japan and the United States. Its product portfolio features a variety of trauma devices, including surgical nails, screws, and plates, engineered for implantation at fracture sites. JMDM also offers joint prostheses, which are designed to replace compromised natural joints and restore functions impaired by disease or injury. Additionally, the company supplies spinal stabilization systems for operations addressing spinal instability, as well as synthetic bone grafts used in the treatment of bone fractures, tumors, and other structural deficiencies. These specialized medical solutions are provided to healthcare professionals and hospitals. Founded in 1973, the firm's headquarters are located in Tokyo, Japan.
Technical Analysis
CYBERDYNE
―
PHC Holdings Corp.
―
Eiken Chemical Co., Ltd.
―
Techno Medica Co., Ltd.
―
Nihon Kohden Corporation
―